Boehringer wins US approval for cancer drug

Boehringer Ingelheim GmbH won approval in the U.S. for its drug to treat a challenging form of lung cancer, offering a growth avenue for the privately-held German pharmaceuticals company.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup